Channel Avatar

Pharma Pill @UCVGEHVihqpLXBPqIa2-eVZw@youtube.com

24K subscribers - no pronouns :c

“The more we know,The more we grow” By keeping above quote

Videos Posts Playlists
Recently Uploaded Popular Oldest
08:11
GMP updates of September 2023
08:04
Top 15 Definition as per USP
08:58
Ipca Laboratories Indore USFDA 483 Observations
13:33
Review INTAS PHARMA || USFDA 483 Observations ||May 2023 ||
06:20
Top 10 HPLC Interview Questions and Answers || For Freshers ||
08:35
Review of Intas Pharma IMPORT ALERT 2023
08:02
Review || IPCA Laboratories || USFDA 483 Observations || Pipria Plant ||
09:58
Review of Cipla Indore USFDA 483 Observations
10:02
Top 20 Stability section Interview QUESTION & ANSWERS || Part-1 ||
08:41
Review of Glenmark GOA Warning Letter
13:02
Review of INTAS PHARMA 483 Observations
10:07
Pharma Updates of Entire Year 2022
08:19
GMP Updates || December 2022 ||
05:24
ICH Q2 R1 || Analytical Method Validation || Identification test by IR ||
09:23
Aurobindo Pharma Unit-9 || USFDA Form 483 Observations || November 2022 ||
08:21
GMP Updates || November 2022 ||
08:02
Biocon Malaysia USFDA 483 observations
08:27
Jubilant Generics || Dehradoon ||USFDA 483 Observations || August 2022 ||
08:04
Working Principle of Analytical Balance ||European pharmacopeia General Chapter 2.1.7 || Part-1 ||
08:03
GMP Updates of October 2022
09:14
Torrent Pharma 483 Observations
11:21
Biocon Ltd Bengaluru 483 Observations || USFDA || August 2022 ||
08:27
GMP Updates of September 2022
08:06
Aurobindo Pharma Unit-11 USFDA 483 Observations August 2022
08:41
Cipla Goa USFDA 483 Observations
08:38
GMP Updates of August 2022
08:18
Sun Pharma Mohali || USFDA 483 Observations || August 2022 ||
05:24
Types of QC Balances
08:17
Top 20 Interview Questions & Answers || Analytical Balances ||
06:49
USP General Chapter 1251 || Weighing on analytical balance || Part-3 ||
06:52
USP General Chapter 41 || Balances || Part-2 ||
04:32
Balance Calibration || Guideline References || Part-1 ||
05:41
GC Calibration Parameters || Learn in simple Language ||
13:34
Lupin Ltd / Novel Laboratories New Jersy|| USFDA 483 Observations || March 2022 ||
05:53
Shilpa Medicare || USFDA 483 Observations || April 2022 ||
08:52
Baxter Pharmaceuticals || USFDA 483 Observations || May 2022||
06:02
Aurobindo Pharma || USFDA 483 Observations || May 2022 ||
09:53
Sun Pharma Halol || USFDA 483|| May 2022||
06:14
Why HPLC Column Die ? || Causes of Poor Column Performance||
07:19
Nitrosamine impurities || USFDA Guideline || Part-1
04:43
Macleods Baddi || USFDA 483 observations ||
03:04
Cadila Healthcare || USFDA Form 483 observations || Jarod Vadodara Gujarat ||
03:18
Drift and Noise Test || HPLC Calibration Series Part-4 ||
05:03
Detector Linearity || HPLC Calibration Series Part-3 ||
05:52
Wavelength Accuracy || HPLC Calibration Series Part-2 ||
08:41
Retesting || 95 % Confidence interval limit || As per MHRA OOS guideline ||
11:54
MHRA || OOS Guideline ||
07:19
CAPA || As per USFDA || Trick to Remember CAPA ||
07:37
FAR || Field Alert Report || USFDA Guideline ||
06:54
Trick to Remember Stability Climatic Zones as Per ICH Guidelines
02:42
Key precautions || UV analysis ||
08:38
USP 621 || HPLC || Chromatographic Parameters Adjustments ||
04:08
Retention Time Shift or Variation Causes || Pharma Pill
07:27
Identified Impurity,Unidentified Impurity, Specified Impurity , Unspecified Impurity as per ICH Q3A
02:57
7 QC tools Short Trick to Remember
05:10
ICH Q3A Impurities in new drug substances (Part-1)
09:35
ICH Q3C Guideline: Residual Solvents #Part-1
03:52
MHRA vs USFDA OOS guideline differences.
02:35
Trick to remember Data Integrity definition as per USFDA
11:38
OOS USFDA guideline Part-1 video reloaded.
Next Page